{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:19:54Z","timestamp":1767921594956,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Italian Ministry of Foreign Affairs and International Cooperation"},{"DOI":"10.13039\/501100001738","name":"Israeli Ministry of Science, Technology & Space","doi-asserted-by":"crossref","award":["3-124040"],"award-info":[{"award-number":["3-124040"]}],"id":[{"id":"10.13039\/501100001738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian Ministry of Health","award":["GR-2013-02358564"],"award-info":[{"award-number":["GR-2013-02358564"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.phrs.2019.104388","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T02:01:31Z","timestamp":1565229691000},"page":"104388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine"],"prefix":"10.1016","volume":"148","author":[{"given":"Paola","family":"Cavalcante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tehila","family":"Mizrachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Barzago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Scandiffio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Bortone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Frangiamore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talma","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Vaknin-Dembinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.104388_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/nyas.13592","article-title":"Serological and experimental studies in different forms of myasthenia gravis","volume":"1413","author":"Vincent","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2019.104388_bib0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.phrs.2019.104388_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis \u2013 autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2019.104388_bib0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","article-title":"Myasthenia gravis: from autoantibodies to therapy","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.phrs.2019.104388_bib0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/WNL.31.2.220","article-title":"No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis","volume":"31","author":"Roses","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104388_bib0030","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104388_bib0035","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","article-title":"The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies","volume":"57","author":"Romi","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2019.104388_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104388_bib0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"MGTX Study Group. Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2019.104388_bib0050","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617749134","article-title":"When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies","volume":"11","author":"Mantegazza","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.phrs.2019.104388_bib0055","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104388_bib0060","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2019.104388_bib0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcp.22066","article-title":"MicroRNAs as gatekeepers of apoptosis","volume":"223","author":"Subramanian","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2019.104388_bib0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2019.104388_bib0075","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","article-title":"The role of miRNA in inflammation and autoimmunity","volume":"12","author":"Singh","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2019.104388_bib0080","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.coi.2012.07.011","article-title":"MicroRNAs and autoimmunity","volume":"24","author":"Ceribelli","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.phrs.2019.104388_bib0085","doi-asserted-by":"crossref","first-page":"e6309","DOI":"10.1371\/journal.pone.0006309","article-title":"Differential micro RNA expression in PBMC from multiple sclerosis patients","volume":"4","author":"Otaegui","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104388_bib0090","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2019.104388_bib0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.phrs.2019.104388_bib0100","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11481-013-9498-9","article-title":"Identification of novel microRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response","volume":"8","author":"Wang","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.phrs.2019.104388_bib0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nyas.13510","article-title":"Circulating microRNAs as potential biomarkers in myasthenia gravis patients","volume":"1412","author":"Punga","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2019.104388_bib0110","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.imbio.2016.06.012","article-title":"A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients","volume":"221","author":"Barzago","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.phrs.2019.104388_bib0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2018.01.008","article-title":"Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues","volume":"17","author":"Cron","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2019.104388_bib0120","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/bib\/bbs082","article-title":"Pharmaco-miR: linking microRNAs and drug effects","volume":"15","author":"Rukov","year":"2014","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.phrs.2019.104388_bib0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/17425255.2018.1472237","article-title":"Current knowledge of microRNA-mediated regulation of drug metabolism in humans","volume":"14","author":"Nakano","year":"2018","journal-title":"Expert Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.phrs.2019.104388_bib0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.phrs.2019.104388_bib0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.23330","article-title":"Recommendations for myasthenia gravis clinical trials","volume":"45","author":"Benatar","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.phrs.2019.104388_bib0140","series-title":"Babraham Bioinformatics FastQC a Quality Control Application for High Throughput Sequence Data","year":"2017"},{"key":"10.1016\/j.phrs.2019.104388_bib0145","series-title":"miRBase: The microRNA Database","year":"2017"},{"key":"10.1016\/j.phrs.2019.104388_bib0150","series-title":"Bowtie 2 Fast and Sensitive Read Alignment","year":"2017"},{"key":"10.1016\/j.phrs.2019.104388_bib0155","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2019.104388_bib0160","series-title":"DIANA Lab Tools","year":"2019"},{"key":"10.1016\/j.phrs.2019.104388_bib0165","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ab.2011.10.022","article-title":"Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling","volume":"421","author":"Viprey","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.phrs.2019.104388_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4939-6563-2_2","article-title":"Functional analysis of miRNAs using the DIANA Tools Online Suite","volume":"1517","author":"Vlachos","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2019.104388_bib0175","series-title":"The miRNA Pharmacogenomics Database","year":"2019"},{"key":"10.1016\/j.phrs.2019.104388_bib0180","series-title":"Bionconductor Open Source Software for Bioinformatics","year":"2017"},{"key":"10.1016\/j.phrs.2019.104388_bib0185","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.1300825","article-title":"Nerve growth factor downregulates inflammatory response in human monocytes through TrkA","volume":"192","author":"Prencipe","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2019.104388_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/tpj.2012.45","article-title":"Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects","volume":"13","author":"Sim","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.phrs.2019.104388_bib0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0091270011435989","article-title":"A new thiopurine S-methyltransferase haplotype associated with intolerance to azathioprine","volume":"53","author":"Colleoni","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104388_bib0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/FPC.0000000000000257","article-title":"A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis","volume":"27","author":"Colleoni","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.phrs.2019.104388_bib0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fneur.2017.00230","article-title":"The role of osteopontin and its gene on glucocorticoid response in myasthenia gravis","volume":"8","author":"Xie","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2019.104388_bib0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-pharmtox-010617-053021","article-title":"Pharmacoepigenetics and toxicoepigenetics: novel mechanistic insights and therapeutic opportunities","volume":"58","author":"Lauschke","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2019.104388_bib0215","doi-asserted-by":"crossref","first-page":"E1028","DOI":"10.3390\/ijms18051028","article-title":"NGF and its receptors in the regulation of inflammatory response","volume":"18","author":"Minnone","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2019.104388_bib0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/aps.2014.135","article-title":"Regulatory networks between neurotrophins and miRNAs in brain diseases and cancers","volume":"36","author":"Shi","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2019.104388_bib0225","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","article-title":"Regulation of nuclear factor-\u03baB in autoimmunity","volume":"34","author":"Sun","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2019.104388_bib0230","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000365917","article-title":"Regulation of a TrkB alternative transcript by microRNAs","volume":"4","author":"Wong","year":"2014","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.phrs.2019.104388_bib0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2199-11-95","article-title":"Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells","volume":"11","author":"Guidi","year":"2010","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.phrs.2019.104388_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-005-0353-8","article-title":"Fc receptors and their role in immune regulation and autoimmunity","volume":"25","author":"Takai","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.phrs.2019.104388_bib0245","first-page":"335","article-title":"Targeting the Fc receptor in autoimmune disease, Expert Opin","volume":"18","author":"Li","year":"2014","journal-title":"Ther. Targets Neurol. Dis."},{"key":"10.1016\/j.phrs.2019.104388_bib0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(02)02635-2","article-title":"Corticosteroid inhibits IL-4 signaling through down-regulation of IL-4 receptor and STAT6 activity","volume":"518","author":"So","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2019.104388_bib0255","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2019.104388_bib0260","doi-asserted-by":"crossref","first-page":"17008","DOI":"10.1038\/nrdp.2017.8","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.phrs.2019.104388_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","article-title":"The role of the glucocorticoid receptor in inflammation and immunity","volume":"120","author":"Baschant","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.phrs.2019.104388_bib0270","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2019.104388_bib0275","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/ijc.25260","article-title":"miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines","volume":"127","author":"Zhu","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2019.104388_bib0280","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00432-011-1114-x","article-title":"MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2","volume":"138","author":"Wang","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.phrs.2019.104388_bib0285","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/acs.molpharmaceut.7b00076","article-title":"Clinically relevant multidrug transporters are regulated by microRNAs along the human intestine","volume":"14","author":"Bruckmueller","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2019.104388_bib0290","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/FPC.0000000000000245","article-title":"MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia","volume":"26","author":"Iparraguirre","year":"2016","journal-title":"Pharmacogenet. Genomics"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819310217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819310217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:00:04Z","timestamp":1760911204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819310217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":58,"alternative-id":["S1043661819310217"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104388","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104388"}}